FDA Adverse Event Injury Summary report: N

SPYSCOPE DS II ACCESS & DELIVERY CATHETER

MDR report key: 11819866 · Received May 13, 2021

Report

Report Number
3005099803-2021-02216
Event Type
Injury
Date Received
May 13, 2021
Date of Event
April 13, 2021
Report Date
May 13, 2021
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
FBN
UDI-DI
08714729965404
PMA / PMN Number
K181439
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PATIENT'S EXACT WEIGHT IS (B)(6) KG. (B)(4). THE COMPLAINANT INDICATED THAT THE DEVICE WAS DISPOSED AND WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A PROBLEM ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A SPYSCOPE DS II ACCESS & DELIVERY CATHETER WAS USED IN THE COMMON BILE DUCT (CBD) DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) WITH SPYGLASS PROCEDURE PERFORMED ON (B)(6) 2021. AFTER THE SPYGLASS PROCEDURE, THE PATIENT WAS PRESENTED TO THE EMERGENCY ROOM LATE EVENING ON (B)(6) 2021 DUE TO UPPER QUADRANT PAIN AND RIGHT SHOULDER PAIN. IT WAS ALSO REPORTED THAT THE PAIN WAS DUE TO PERIHEPATIC FLUID ACCUMULATION AND A DRAIN WAS PLACED TO ELIMINATE THE FLUID. THE SAME SPYSCOPE DS II DEVICE WAS USED THROUGHOUT TO COMPLETE THE PROCEDURE. NO DEVICE PROBLEMS WERE REPORTED FOR THE SPYSCOPE DS II AND THE CAUSE OF THE PATIENT'S PAIN AND PERIHEPATIC FLUID ACCUMULATION WERE NOT DETERMINED. ADDITIONAL INFORMATION WAS RECEIVED ON APRIL 26, 2021 REPORTING THAT THE PATIENT WAS DOING WELL AND WAS SCHEDULED FOR A WHIPPLE PROCEDURE A WEEK LATER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
712852 SPYSCOPE DS II ACCESS & DELIVERY CATHETER CHOLEDOCHOSCOPE AND ACCESSORIES, FLEXIBLE/RIGID FBN BOSTON SCIENTIFIC CORPORATION M00546610 08714729965404

Patients

Seq Age Sex Outcome Treatment
1 57 YR Hospitalization| R